Niche PBFR market Owens Recovery Science focuses on personalized blood flow restriction training and equipment, presenting a specialized opportunity to upsell training partnerships, certifications, and companion devices to medical professionals seeking PBFR solutions.

Partnership leverage Existing partnerships with Delfi PTS tourniquet technology and collaborations with Springbok Analytics and APCRaleigh indicate a strong channel for expanding distribution, co-marketing, and integrated decision-support tools to enhance PBFR adoption.

Targeted buyers Primary customers are PTs, OTs, ATCs, DCs and other medical professionals; sales efforts can focus on clinics, therapy centers, and hospitals that emphasize PBFR protocols and safety features.

Safety and compliance The emphasis on FDA‑approved tourniquet technology and safety features of the Delfi PTS provides a compelling value proposition for facilities seeking compliant, risk-managed PBFR equipment and training.

Growth potential With annual revenue in the low multi‑million range and a global leadership claim in PBFR education, there is room to expand into larger clinical networks, training programs, and scalable certification offerings.